Koyfin Home > Directory > Health Care > Kiniksa Pharmaceuticals Ltd > Net Debt / (EBITDA-CAPEX)

Kiniksa Pharmaceuticals Ltd Net Debt / (EBITDA-CAPEX) Chart (KNSA)

Kiniksa Pharmaceuticals Ltd annual/quarterly Net Debt / (EBITDA-CAPEX) from 2017 to 2020.
  • Kiniksa Pharmaceuticals Ltd Net Debt / (EBITDA-CAPEX) for the quarter ending September 09, 2020 was $2m a 20.16% increase of 0m year over year
  • Kiniksa Pharmaceuticals Ltd Net Debt / (EBITDA-CAPEX) for the last 12 months ending September 09, 2020 was $3m a 49.21% increase of 1m year over year
  • Kiniksa Pharmaceuticals Ltd Annual Net Debt / (EBITDA-CAPEX) for 2019 was $1m a -99.50% decrease of -1m from 2018
  • Kiniksa Pharmaceuticals Ltd Annual Net Debt / (EBITDA-CAPEX) for 2018 was $3m a 74.37% increase of 2m from 2017
  • Kiniksa Pharmaceuticals Ltd Annual Net Debt / (EBITDA-CAPEX) for 2017 was $1m a -235.25% decrease of -2m from 2016
Other Ratios Metrics:
  • Kiniksa Pharmaceuticals Ltd Other Liabilities for the quarter ending September 09, 2018 was $0m
View Chart On Koyfin

Quarterly KNSA Net Debt / (EBITDA-CAPEX) Data

09/2020$2m
06/2020$2m
03/2020$2m
12/2019$2m
09/2019$2m
06/2019$2m
03/2019$1m
12/2018$2m
09/2018$3m
06/2018$4m

Annual KNSA Net Debt / (EBITDA-CAPEX) Data

2019$1m
2018$3m
2017$1m
2016$2m